COVID-19 cytokine storm: the interplay between inflammation and coagulation
RJ Jose, A Manuel - The Lancet Respiratory Medicine, 2020 - thelancet.com
Coronavirus disease 2019 (COVID-19) has spread rapidly throughout the globe. It is associated
with significant mortality, particularly in at-risk groups with poor prognostic features at …
with significant mortality, particularly in at-risk groups with poor prognostic features at …
Considerations for safety in the use of systemic medications for psoriasis and atopic dermatitis during the COVID‐19 pandemic
JW Ricardo, SR Lipner - Dermatologic Therapy, 2020 - Wiley Online Library
Coronavirus disease 2019 (COVID‐19) is responsible for at least 2 546 527 cases and 175
812 deaths as of April 21, 2020. Psoriasis and atopic dermatitis (AD) are common, chronic, …
812 deaths as of April 21, 2020. Psoriasis and atopic dermatitis (AD) are common, chronic, …
Sedation for flexible bronchoscopy: current and emerging evidence
Flexible bronchoscopy is commonly performed by respiratory physicians and is the gold
standard for directly visualising the airways, allowing for numerous diagnostic and therapeutic …
standard for directly visualising the airways, allowing for numerous diagnostic and therapeutic …
Safety of current therapies for onychomycosis
JW Ricardo, SR Lipner - Expert opinion on drug safety, 2020 - Taylor & Francis
Introduction Onychomycosis is the most common nail disease seen in clinical practice.
Treatment options include systemic and topical therapies, as well as devices. Following clinical …
Treatment options include systemic and topical therapies, as well as devices. Following clinical …
[HTML][HTML] Protection against Streptococcus pneumoniae lung infection after nasopharyngeal colonization requires both humoral and cellular immune responses
R Wilson, JM Cohen, RJ Jose, C de Vogel… - Mucosal …, 2015 - Elsevier
Streptococcus pneumoniae is a common cause of pneumonia and infective exacerbations
of chronic lung disease, yet there are few data on how adaptive immunity can specifically …
of chronic lung disease, yet there are few data on how adaptive immunity can specifically …
Macrophage migration inhibitory factor–CXCR4 is the dominant chemotactic axis in human mesenchymal stem cell recruitment to tumors
S Lourenco, VH Teixeira, T Kalber, RJ Jose… - The Journal of …, 2015 - journals.aai.org
Mesenchymal stromal cells (MSCs) are inherently tumor homing and can be isolated, expanded,
and transduced, making them viable candidates for cell therapy. This tumor tropism has …
and transduced, making them viable candidates for cell therapy. This tumor tropism has …
[HTML][HTML] Does coronavirus disease 2019 disprove the obesity paradox in acute respiratory distress syndrome?
RJ Jose, A Manuel - Obesity (Silver Spring, Md.), 2020 - ncbi.nlm.nih.gov
TO THE EDITOR: We are writing in reference to the editorial “COVID 19 and the Patient with
Obesity–The Editors Speak Out”(1). Obesity is associated with a decrease in mortality in …
Obesity–The Editors Speak Out”(1). Obesity is associated with a decrease in mortality in …
[HTML][HTML] Naturally acquired human immunity to pneumococcus is dependent on antibody to protein antigens
R Wilson, JM Cohen, M Reglinski, RJ Jose… - PLoS …, 2017 - journals.plos.org
Naturally acquired immunity against invasive pneumococcal disease (IPD) is thought to be
dependent on anti-capsular antibody. However nasopharyngeal colonisation by …
dependent on anti-capsular antibody. However nasopharyngeal colonisation by …
The role of CT in case ascertainment and management of COVID-19 pneumonia in the UK: insights from high-incidence regions
…, J Barnett, V Kouranos, OM Kon, R José… - The Lancet …, 2020 - thelancet.com
1 Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus
in Wuhan, China. Lancet 2020; 395: 497–506. 2 Yin Y, Wunderink RG. MERS, SARS …
in Wuhan, China. Lancet 2020; 395: 497–506. 2 Yin Y, Wunderink RG. MERS, SARS …
Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: a study of injectable use and toxicity in practice
A Sturdy, A Goodman, RJ José, A Loyse… - Journal of …, 2011 - academic.oup.com
Background Multidrug-resistant tuberculosis (MDR-TB) is an increasing challenge to health
services globally. Although new drugs are in development, current guidelines still …
services globally. Although new drugs are in development, current guidelines still …